Viasat identified as latest victim in China-backed surveillance hack – Bloomberg

Viasat identified as latest victim in China-backed surveillance hack – Bloomberg
Source link

Viasat identified as latest victim in China-backed surveillance hack – Bloomberg
Source link
By Lawrence G. McMillan Apple ($AAPL) has just triggered a buy signal based on our weighted put-call ratio, one of our more reliable sentiment-based indicators for this stock. Historically, these signals have generally preceded intermediate-term rallies in $AAPL, and the current setup looks promising. Source link
Despite a constant stream of concerning news in the last month, the S&P 500 remains less than 5% below its all-time high. That’s an impressive performance, considering Brent crude oil is nudging up against US$100 and could head much higher. I just paid $124 to fill up the tank this morning. Ouch. My reading of…
The Bank of Canada has lowered its benchmark interest rate to 2.75% from 5% in April 2024. Moreover, economists are predicting two more rate cuts this year and expect the benchmark interest rate to fall to 2.25%. In this low-interest environment, investors can look at acquiring quality dividend stocks to boost their passive income. Meanwhile,…
March 24, 2025March 24, 2025 Shares of Power Mech Projects Ltd skyrocketed 17% on Monday, 24 March, after the company announced securing an order worth Rs 579 crore from BHEL. In its regulatory filing, the company said that they had secured an order from Bharat Heavy Electricals Ltd (BHEL)…
Indian equity markets closed sharply lower on Thursday as lingering tensions between the US and Iran triggered broad-based selling. The benchmark indices snapped their three-session winning streak, weighed down by losses in auto, financial, IT and consumer stocks. The Nifty fell 365 points, or 1.41%, to settle at 25,454.35, while the 30-share BSE Sensex ended…
Merck & Co., Inc. NYSE: MRK is one of the largest pharmaceutical firms in the world. The firm ranks fourth behind giants like Eli Lilly NYSE: LLY and Novo Nordisk NYSE: NVO, with a market capitalization of $294 billion. The company’s forward price-to-earnings (P/E) ratio sits at 13x. Compared to a peer group of the…